News
In July, Trump had threatened to lift pharmaecutical tariffs to 200%, but speaking on CNBC on 5 August, Trump said they could eventually go as high as 250%. "We want pharmaceuticals made in our ...
Hosted on MSN39m
Voices: Is ‘black-market Ozempic’ ever worth the risk?
Ozempic has made its manufacturer, Novo Nordisk, Europe’s most valuable company, and has gone from Hollywood’s “dirty little ...
Semaglutide, or Ozempic as it is branded ... In research conducted by its billionaire manufacturer, the Danish-based pharmaceutical company Novo Nordisk, patients lost an average of 17 per cent of ...
Ascendis Pharma's TransCon platform shows promise, but challenges with rollout, competition, and execution risks lead to a Hold rating.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results